Tianfu Wen

机构：Sichuan University, West China Hospital of Sichuan University, State Key Laboratory of Biotherapy · ORCID：0000-0003-1979-9775

发表论文 50 篇 · 总被引 1073 次 · h-index 21

代表论文

• Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus (2018 · HepatoBiliary Surgery and Nutrition · 被引 115)
• Novel techniques and preliminary results of ex vivo liver resection and autotransplantation for end-stage hepatic alveolar echinococcosis: A study of 31 cases (2017 · American Journal of Transplantation · 被引 87)
• Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial (2025 · The Lancet · 被引 49)
• China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition) (2025 · Liver Cancer · 被引 41)
• A Novel Index in Hepatocellular Carcinoma Patients After Curative Hepatectomy: Albumin to Gamma-Glutamyltransferase Ratio (AGR) (2019 · Frontiers in Oncology · 被引 29)
• Role of liver resection in treating intermediate and advanced stage adolescent and young adult hepatocellular carcinoma patients: A propensity-matching cohort study (2018 · International Journal of Surgery · 被引 28)